We are live on ! Find out more
Man Group

Man Group Portfolio holdings

AUM $55.1B
1-Year Est. Return 24.23%
This Fund
S&P 500
This Quarter Est. Return
+9.58%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
AUM
$25.4B
AUM Growth
+$5.58B
Cap. Flow
+$3.58B
Cap. Flow %
14.09%
Top 10 Hldgs %
15.16%
Holding
1,957
New
313
Increased
881
Reduced
499
Closed
190

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$153M
2
HD icon
Home Depot
HD
+$120M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$89.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$88.8M
5
F icon
Ford
F
+$87.1M

Sector Composition

Rank Sector Weight
1 Technology 21.25%
2 Consumer Discretionary 15.33%
3 Healthcare 13.64%
4 Financials 12.62%
5 Industrials 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANF icon
1301
Abercrombie & Fitch
ANF
$4.17B
$1.06M ﹤0.01%
76,179
+9,328
+14% +$109K
RTX icon
1302
RTX Corp
RTX
$287B
$1.06M ﹤0.01%
18,466
+4,701
+34% +$286K
BBSI icon
1303
Barrett Business Services
BBSI
$976M
$1.06M ﹤0.01%
80,744
-75,140
-48% -$1.03M
CRAI icon
1304
CRA International
CRAI
$1.1B
$1.05M ﹤0.01%
28,055
-6,001
-18% -$248K
UTHR icon
1305
United Therapeutics
UTHR
$26.3B
$1.05M ﹤0.01%
10,368
-43,757
-81% -$4.8M
NVEC icon
1306
NVE Corp
NVEC
$569M
$1.04M ﹤0.01%
21,259
+3,560
+20% +$197K
APA icon
1307
APA Corp
APA
$12.8B
$1.03M ﹤0.01%
109,050
+14,861
+16% +$204K
KPTI icon
1308
Karyopharm Therapeutics
KPTI
$168M
$1.03M ﹤0.01%
+4,709
New +$1.15M
LNG icon
1309
Cheniere Energy
LNG
$56.5B
$1.02M ﹤0.01%
21,948
-32,264
-60% -$1.64M
DSGX icon
1310
Descartes Systems
DSGX
$5.84B
$1.01M ﹤0.01%
+17,806
New +$985K
CDNA icon
1311
CareDx
CDNA
$1.92B
$1.01M ﹤0.01%
+26,599
New +$898K
XRAY icon
1312
Dentsply Sirona
XRAY
$2.59B
$1.01M ﹤0.01%
+23,034
New +$1.02M
ASMB icon
1313
Assembly Biosciences
ASMB
$506M
$1.01M ﹤0.01%
5,102
+1,691
+50% +$426K
FWONK icon
1314
Liberty Media Series C
FWONK
$24.3B
$1M ﹤0.01%
28,617
+346
+1% +$12.2K
VMI icon
1315
Valmont Industries
VMI
$9.44B
$999K ﹤0.01%
8,048
+2,798
+53% +$344K
SWAV
1316
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$999K ﹤0.01%
+13,176
New +$747K
ITOS
1317
DELISTED
iTeos Therapeutics
ITOS
$997K ﹤0.01%
+40,423
New +$1.09M
PHR icon
1318
Phreesia
PHR
$632M
$996K ﹤0.01%
+30,981
New +$922K
CMCO icon
1319
Columbus McKinnon
CMCO
$465M
$991K ﹤0.01%
29,926
+1,092
+4% +$37.9K
TVTX icon
1320
Travere Therapeutics
TVTX
$5.33B
$989K ﹤0.01%
53,577
+4,807
+10% +$93.4K
TPR icon
1321
Tapestry
TPR
$28.8B
$982K ﹤0.01%
62,816
+42,563
+210% +$627K
CRSP icon
1322
CRISPR Therapeutics
CRSP
$4.58B
$979K ﹤0.01%
11,706
-73,581
-86% -$6.53M
QQQ icon
1323
Invesco QQQ Trust
QQQ
$455B
$977K ﹤0.01%
3,515
+170
+5% +$46.1K
STC icon
1324
Stewart Information Services
STC
$2.05B
$973K ﹤0.01%
+22,247
New +$899K
SPNT icon
1325
SiriusPoint
SPNT
$2.98B
$971K ﹤0.01%
139,718
-202,159
-59% -$1.63M

Similar funds

Man Group's Q3 2020 Portfolio in Review

As of Q3 2020, Man Group held 1,957 positions worth $25.4B, up 28% from $19.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Man Group deployed $3.58B of net new capital in Q3 2020, opening 313 new positions and adding to 881 existing holdings. Its largest new stake was SS&C Technologies: 585,849 shares worth $35.5M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Qualcomm, an estimated $149M trimmed.

  • Man Group's largest Q3 2020 buy was SS&C Technologies: 585,849 shares worth $35.5M.
  • Man Group added most to Citigroup in Q3 2020, an estimated $153M increase.
  • Man Group's biggest Q3 2020 reduction was Qualcomm, cutting an estimated $149M.
  • Man Group fully exited Delta Air Lines in Q3 2020, selling an estimated $28.8M.
  • Man Group's ten largest holdings make up 15% of its $25.4B portfolio in Q3 2020.
  • Man Group opened 313 new positions and closed 190 in Q3 2020.
  • Man Group's portfolio value rose 28% quarter-over-quarter to $25.4B.

Based on Man Group's 13F filing for Q3 2020, filed 16 Nov 2020.